AdvertisementDrugmakers Play The Patent Game To Lock In Prices, Block CompetitorsSeptember 28, 2018Sarah Jane TribblefacebookEmailPurdue Pharma, maker of the opioid OxyContin, has a subsidiary that won a patent for a treatment for opioid addiction. (Bloomberg via Getty Images)
